International Milk Composition (IMiC) Consortium

NCT05119166 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-05-07

No results posted yet for this study

Summary

The IMiC Consortium will analyze milk from 1000 mother-infant dyads across 4 diverse settings (Tanzania, Pakistan, Burkina Faso and Canada). Samples will be stored centrally at the Manitoba Interdisciplinary Lactation Centre (MILC) biorepository and distributed to multiple laboratories for analysis of macronutrients, micronutrients, oligosaccharides, growth factors, immunoglobulins, cytokines, metabolites and microbes. Data will be harmonized and stored in a central database, and diverse statistical methods will be applied for data integration and analysis.

Conditions

  • Infant Growth
  • Maternal Health
  • Infant Nutrition

Interventions

DIETARY_SUPPLEMENT

Vitamin B3

ELICIT Study: Factorial design RCT of nicotinamide (vitamin B3) to mothers and infants, and antimicrobial prophylaxis (Azithromycin) to infants.

BIOLOGICAL

Azithromycin

ELICIT Study: Factorial design RCT of nicotinamide (vitamin B3) to mothers and infants, and antimicrobial prophylaxis (Azithromycin) to infants. VITAL Pakistan Study: 3-arm RCT of fortified food supplement (protein energy) during lactation, with or without azithromycin prophylaxis for infant.

DIETARY_SUPPLEMENT

Fortified food supplement

VITAL Study: 3-arm RCT of fortified food supplement (protein energy) during lactation, with or without azithromycin prophylaxis for infant. MISAMEIII Study: 2x2 cross-over efficacy RCT of fortified food supplement (folic acid/iron +/- peanut spread) during pregnancy and/or lactation; unmasked (open label).

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER
  • Stanford University

    collaborator OTHER
  • The University of Western Australia

    collaborator OTHER
  • University of Idaho

    collaborator OTHER
  • Ludwig-Maximilians - University of Munich

    collaborator OTHER
  • Johns Hopkins University

    collaborator OTHER
  • Cedars-Sinai Medical Center

    collaborator OTHER
  • Sapient Bioanalytics

    collaborator UNKNOWN
  • University of California, Davis

    collaborator OTHER
  • University of California, San Diego

    collaborator OTHER
  • University of Virginia

    collaborator OTHER
  • Aga Khan University

    collaborator OTHER
  • University Ghent

    collaborator OTHER
  • University of California, Berkeley

    collaborator OTHER
  • University Health Network, Toronto

    collaborator OTHER
  • USDA Beltsville Human Nutrition Research Center

    collaborator FED
  • Antigen Discovery Inc

    collaborator UNKNOWN
  • USDA, Western Human Nutrition Research Center

    collaborator FED
  • University of Manitoba

    lead OTHER

Principal Investigators

  • Meghan B Azad · University of Manitoba, CHILD Cohort Study

  • Estomih Mduma · Haydom Lutheran Hospital, ELICIT Trial

  • Fyezah Jehan · Aga Khan University Pakistan, VITAL Trial

  • Laeticia Celine Toe · Institut de Recherche en Science de la Santa, MISAMEIII Trial

  • PJ Subbarao · SickKids, CHILD Study

  • Yasir Shafiq · Aga Khan University Pakistan, VITAL Trial

  • Mark D DeBoer · University of Virginia, VITAL Trial

  • Patrick Kolsteren · Ghent University, MISAMEIII Trial

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-17
Primary Completion
2026-10-30
Completion
2026-10-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05119166 on ClinicalTrials.gov